Pfizer Inc (MIL:1PFE)
€ 24.62 -0.33 (-1.32%) Market Cap: 140.00 Bil Enterprise Value: 193.63 Bil PE Ratio: 34.77 PB Ratio: 1.58 GF Score: 59/100

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 04:45PM GMT
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Great. Thank you very much for joining us today in post-learn session. We'll keep it entertaining so that we don't -- yes. Thank you very much. And my name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and we have Pfizer management team today with us. We have Annaliesa Anderson, she's SVP and CSO, Vaccine R&D; and Rodrigo Puga, he's the U.S. Commercial and Global Business Lead of Internal Medicine; and we also have Chris Stevo, Head of IR at Pfizer. Thank you all for joining us today.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

And Mohit, if I can just make -- briefly make a forward-looking statement and I'll let you all get to it. So I just wanted to inform you that we're going to be making forward-looking statements or may be making forward-looking statements today and anything we say is only valid as of today. And if you have any more questions on forward-looking statements, please see the relevant sections in our SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot